Vor Biopharma Future Growth
Future criteria checks 0/6
Vor Biopharma is forecast to grow earnings and revenue by 9.3% and 69.2% per annum respectively while EPS is expected to grow by 19.1% per annum.
Key information
9.3%
Earnings growth rate
19.1%
EPS growth rate
| Biotechs earnings growth | 23.2% |
| Revenue growth rate | 69.2% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 12 Apr 2024 |
Recent future growth updates
Recent updates
Here's Why We're Watching Vor Biopharma's (NASDAQ:VOR) Cash Burn Situation
Dec 05
Will Vor Biopharma (NASDAQ:VOR) Spend Its Cash Wisely?
Aug 18Vor Biopharma (NASDAQ:VOR) Is In A Good Position To Deliver On Growth Plans
May 05Is Vor Biopharma Inc. (NASDAQ:VOR) Trading At A 49% Discount?
Mar 13We Think Vor Biopharma (NASDAQ:VOR) Needs To Drive Business Growth Carefully
Oct 19Vor Bio appoints Eyal C. Attar as chief medical officer
Oct 12Is Vor Biopharma (NASDAQ:VOR) In A Good Position To Invest In Growth?
Jun 18Vor Biopharma (NASDAQ:VOR) Is In A Good Position To Deliver On Growth Plans
Mar 05Vor Biopharma (NASDAQ:VOR) Is In A Good Position To Deliver On Growth Plans
Aug 30Vor Biopharma: Targeted Therapies For Transplants
Jun 30We're Not Very Worried About Vor Biopharma's (NASDAQ:VOR) Cash Burn Rate
May 10Vor Biopharma EPS misses by $0.03
May 06Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 10 | -119 | -9 | -151 | 5 |
| 12/31/2025 | 1 | -115 | -91 | -134 | 7 |
| 12/31/2024 | N/A | -102 | -95 | -128 | 7 |
| 12/31/2023 | N/A | -118 | -101 | -100 | N/A |
| 9/30/2023 | N/A | -116 | -96 | -95 | N/A |
| 6/30/2023 | N/A | -106 | -87 | -86 | N/A |
| 3/31/2023 | N/A | -98 | -93 | -87 | N/A |
| 12/31/2022 | N/A | -92 | -94 | -85 | N/A |
| 9/30/2022 | N/A | -86 | -94 | -84 | N/A |
| 6/30/2022 | N/A | -81 | -92 | -83 | N/A |
| 3/31/2022 | N/A | -78 | -79 | -74 | N/A |
| 12/31/2021 | N/A | -70 | -73 | -69 | N/A |
| 9/30/2021 | N/A | -70 | -69 | -65 | N/A |
| 6/30/2021 | N/A | -65 | -61 | -56 | N/A |
| 3/31/2021 | N/A | -56 | -53 | -48 | N/A |
| 12/31/2020 | N/A | -49 | -40 | -36 | N/A |
| 9/30/2020 | N/A | -36 | -31 | -28 | N/A |
| 6/30/2020 | N/A | -26 | -25 | -23 | N/A |
| 3/31/2020 | N/A | -19 | -17 | -15 | N/A |
| 12/31/2019 | N/A | -13 | -11 | -10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VOR is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: VOR is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: VOR is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: VOR is forecast to have no revenue next year.
High Growth Revenue: VOR is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if VOR's Return on Equity is forecast to be high in 3 years time